| 1634 |
Supervision by MO-TC at TU level |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1635 |
Supervision by DTO at TU level |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1641 |
Program Monitoring Indicators |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1642 |
NTEP TB Index - Indicators |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1643 |
NTEP Performance Indicator - Percentage of Target TB Notification Achieved |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1645 |
NTEP Performance Indicator - Percentage of TB Notified Patients with Known HIV Status |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1646 |
RCA for low performance of Percentage of TB Notified Patients with known HIV Status |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1649 |
NTEP Performance Indicator - Treatment Success Rate |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1651 |
NTEP Performance Indicator - Percentage of Eligible Beneficiaries Paid Under Ni-kshay Poshan Yojana |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1654 |
RCA for low performance in in Percentage Treatment initiation of RR/MDR-TB Cases |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1655 |
NTEP Performance Indicator - Percentage Expenditure Against Approved Record of Proceedings (ROP) |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1657 |
NTEP Performance Indicator - Percentage of Children given Chemoprophylaxis from the Total Eligible Children Identified |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1658 |
RCA for low performance in Percentage of Children given TPT from the Total Eligible Children Identified |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1659 |
NTEP Performance Indicator - Percentage of People Living with HIV (PLHIV) given INH Preventive Treatment (IPT) Against Total Eligible PLHIV |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1683 |
Meetings at TU level |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1684 |
Conducting review meetings at TU/Block level |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1795 |
Factors Affecting the Severity of TB Disease |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 2042 |
Random Blinded ReChecking [RBRC] Interpreting Feedback |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 2089 |
Zoonotic TB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 2090 |
Zoonotic TB: Mode of transmission |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 2091 |
Zoonotic TB: Signs and symptoms |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 2092 |
Zoonotic TB: Testing and diagnosis |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 2093 |
Zoonotic TB: Treatment and management |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 2094 |
Zoonotic TB: Prevention |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 3084 |
Case study: Percentage of Eligible Beneficiaries Paid under Ni-kshay Poshan Yojana |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 3085 |
Case Study: Percentage of TB Notified Cases with Universal Drug Susceptibility Testing Done |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 3086 |
Case Study: Percentage of TB Notified Patients with Known HIV Status |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 3087 |
Case Study: Percentage Expenditure Against Approved Record of Proceedings [ROP] |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4395 |
Adherence Management Framework |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4397 |
Adherence Management - Summary Workflow |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
